Ratanarat Ranistha, Promsin Panuwat, Srivijitkamol Apiradee, Leemingsawat Chantanij, Permpikul Chairat
Division of Critical Care Medicine, Department of Medicine, Faculty of Medicine, Siriraj hospital, Mahidol University, Bangkok, Thailand.
J Med Assoc Thai. 2010 Jan;93 Suppl 1:S187-95.
The reported incidence of critical illness-related corticosteroid insufficiency (CIRCI) varies widely, depending on the patient population studied and the diagnostic criteria used. Surviving Sepsis Campaign guidelines suggest that corticosteroid therapy should be considered for adult septic shock when hypotension responds poorly to adequate fluid resuscitation and vasopressors, regardless of any results of diagnostic tests. However, steroid treatment may be associated with an increase risk of infection. This study aims to identify the best diagnostic tool for predicting responsiveness to corticosteroid therapy in Thai septic shock patients with poorly responsive to fluid resuscitation and vasopressors.
Twenty-nine septic shock patients who were poorly responsive to fluid therapy and vasopressors were studied. A baseline serum total cortisol was measured in all patients and then 250 mcg corticotropin was injected to patients. Cortisol level was obtained 30 and 60 minutes after injection. All patients were given hydrocortisone (100 mg i.v., then 200 mg i.v. in 24 hrs for at least 5 days). Patients were considered steroid responsive if vasopressor agent could be discontinued within 48 hrs after the first dose of hydrocortisone.
Hospital mortality was 62% in which 45% of the patients were steroid responsive. Baseline serum cortisol was 27.6 +/- 11.4 microg/dl in the steroid-responsive patients compared with 40 +/- 16.9 microg/dl in the steroid-nonresponsive patients (p = 0.03). The area under the ROC curves for predicting steroid responsiveness was 0.72 for baseline cortisol level. Serum cortisol level of 35 microg/dl or less was the most accurate diagnostic threshold to determine hemodynamic response to hydrocortisone treatment (p = 0.04). Using baseline cortisol level of < or = 35 microg/dl to diagnose adrenal insufficiency, the sensitivity was 85%, the specificity was 62% and the accuracy was 72%. A use of (delta cortisol) showed sensitivity of 50%, specificity of 30% and accuracy of 41%.
Baseline cortisol level < or = 35 microg/dl is a useful diagnostic threshold for diagnosis of steroid responsiveness in Thai patients with septic shock and ACTH stimulation test should not be used.
据报道,危重病相关皮质类固醇功能不全(CIRCI)的发病率差异很大,这取决于所研究的患者群体和所使用的诊断标准。《拯救脓毒症运动指南》建议,对于成人脓毒症休克患者,当低血压对充分的液体复苏和血管加压药反应不佳时,无论诊断测试结果如何,都应考虑使用皮质类固醇治疗。然而,类固醇治疗可能会增加感染风险。本研究旨在确定在泰国对液体复苏和血管加压药反应不佳的脓毒症休克患者中预测对皮质类固醇治疗反应性的最佳诊断工具。
研究了29例对液体治疗和血管加压药反应不佳的脓毒症休克患者。测量所有患者的基线血清总皮质醇水平,然后向患者注射250微克促肾上腺皮质激素。注射后30分钟和60分钟获取皮质醇水平。所有患者均接受氢化可的松治疗(静脉注射100毫克,然后在24小时内静脉注射200毫克,至少持续5天)。如果在第一剂氢化可的松后48小时内可以停用血管加压药,则认为患者对类固醇有反应。
医院死亡率为62%,其中45%的患者对类固醇有反应。对类固醇有反应的患者基线血清皮质醇为27.6±11.4微克/分升,而对类固醇无反应的患者为40±16.9微克/分升(p = 0.03)。预测类固醇反应性的ROC曲线下面积对于基线皮质醇水平为0.72。血清皮质醇水平为35微克/分升或更低是确定对氢化可的松治疗的血流动力学反应的最准确诊断阈值(p = 0.04)。使用基线皮质醇水平≤35微克/分升诊断肾上腺功能不全,敏感性为85%,特异性为62%,准确性为72%。使用(皮质醇变化值)显示敏感性为50%,特异性为30%,准确性为41%。
基线皮质醇水平≤35微克/分升是诊断泰国脓毒症休克患者类固醇反应性的有用诊断阈值,不应使用促肾上腺皮质激素刺激试验。